Progeny-based genomic selection reveals untapped genetic potential in an underutilized medicinal plant, Perilla frutescens

preprint OA: closed
Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-08 · read from full text

The preprint studied whether progeny-based genomic selection can improve multiple medicinal compound levels in red perilla (Perilla frutescens), using a cross-selection strategy that prioritized segregation variance via predicted additive genotypic values, followed by actual crossing experiments. In the G2 generation, progeny from genomic selection-based crosses (Crs1–Crs7) outperformed phenotypic selection crosses (Crs8) by showing a higher mean, greater variance, and better top individuals, with the best G2 line exhibiting nearly twofold higher levels of two target compounds compared with the existing cultivar ‘Sekiho’. The work explicitly notes that it is a preprint and has not been peer reviewed. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Despite their substantial therapeutic value, medicinal plants have undergone limited genetic improvement through breeding because of the scarcity of expert breeders. Moreover, quantifying bioactive compounds is expensive. Genomic selection, which leverages genome-wide markers to predict breeding values and assemble favorable alleles, offers a practical way to unlock latent genetic potential. As a model case, we evaluated genomic selection in red perilla ( Perilla frutescens ). Building on previous work, we implemented a cross-selection strategy that prioritized segregation variance by selecting crosses based on predicted additive genotypic values of the progeny, and evaluated its effectiveness through actual crossing experiments targeting three key medicinal compounds. Progeny from genomic selection-based crosses (Crs1–Crs7) outperformed those from phenotypic selection (Crs8) in the G 2 generation, demonstrating a higher mean, greater variance, and superior top individuals. The best G 2 individual exhibited nearly twofold higher levels of two target compounds relative to the existing cultivar ‘Sekiho’. This study provides the first empirical demonstration that genomic selection can improve multiple medicinal compounds in red perilla and highlights the effectiveness of cross-selection based on predicted progeny performance. In addition, the evidence presented here supports the broader application of genomic selection in underutilized medicinal plants.
Full text 12,720 characters · extracted from preprint-html · click to expand
Progeny-based genomic selection reveals untapped genetic potential in an underutilized medicinal plant, Perilla frutescens | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Progeny-based genomic selection reveals untapped genetic potential in an underutilized medicinal plant, Perilla frutescens Sei Kinoshita, Kengo Sakurai, Takahiro Tsusaka, Miki Sakurai, and 3 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-9216494/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Despite their substantial therapeutic value, medicinal plants have undergone limited genetic improvement through breeding because of the scarcity of expert breeders. Moreover, quantifying bioactive compounds is expensive. Genomic selection, which leverages genome-wide markers to predict breeding values and assemble favorable alleles, offers a practical way to unlock latent genetic potential. As a model case, we evaluated genomic selection in red perilla ( Perilla frutescens ). Building on previous work, we implemented a cross-selection strategy that prioritized segregation variance by selecting crosses based on predicted additive genotypic values of the progeny, and evaluated its effectiveness through actual crossing experiments targeting three key medicinal compounds. Progeny from genomic selection-based crosses (Crs1–Crs7) outperformed those from phenotypic selection (Crs8) in the G 2 generation, demonstrating a higher mean, greater variance, and superior top individuals. The best G 2 individual exhibited nearly twofold higher levels of two target compounds relative to the existing cultivar ‘Sekiho’. This study provides the first empirical demonstration that genomic selection can improve multiple medicinal compounds in red perilla and highlights the effectiveness of cross-selection based on predicted progeny performance. In addition, the evidence presented here supports the broader application of genomic selection in underutilized medicinal plants. Crossing experiment genome-assisted breeding genomic selection medicinal plants Perilla frutescens Full Text Additional Declarations No competing interests reported. Supplementary Files RPGSsupplement.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-9216494","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":615483556,"identity":"1e5b1add-abc5-4fa8-b2f3-e0b2ace47b79","order_by":0,"name":"Sei Kinoshita","email":"","orcid":"","institution":"The University of Tokyo","correspondingAuthor":false,"prefix":"","firstName":"Sei","middleName":"","lastName":"Kinoshita","suffix":""},{"id":615483557,"identity":"456cab74-1b23-41e3-9fd8-6138af75d3ef","order_by":1,"name":"Kengo Sakurai","email":"","orcid":"","institution":"The University of Tokyo","correspondingAuthor":false,"prefix":"","firstName":"Kengo","middleName":"","lastName":"Sakurai","suffix":""},{"id":615483558,"identity":"b556a285-68d1-4bb2-b4a0-9101d6061bc4","order_by":2,"name":"Takahiro Tsusaka","email":"","orcid":"","institution":"TSUMURA \u0026 CO.","correspondingAuthor":false,"prefix":"","firstName":"Takahiro","middleName":"","lastName":"Tsusaka","suffix":""},{"id":615483559,"identity":"182bb465-de63-4436-8280-66fdeea58e04","order_by":3,"name":"Miki Sakurai","email":"","orcid":"","institution":"LAO TSUMURA CO., LTD.","correspondingAuthor":false,"prefix":"","firstName":"Miki","middleName":"","lastName":"Sakurai","suffix":""},{"id":615483560,"identity":"f4fb5538-6980-456e-972a-380ab227d3a9","order_by":4,"name":"Kenta Shirasawa","email":"","orcid":"","institution":"Kazusa DNA Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Kenta","middleName":"","lastName":"Shirasawa","suffix":""},{"id":615483561,"identity":"d491adfa-c5bb-4238-9aae-d44339f3c821","order_by":5,"name":"Sachiko Isobe","email":"","orcid":"","institution":"The University of Tokyo","correspondingAuthor":false,"prefix":"","firstName":"Sachiko","middleName":"","lastName":"Isobe","suffix":""},{"id":615483562,"identity":"022d5b82-84e3-46f9-878b-1d3bd22e0483","order_by":6,"name":"Hiroyoshi Iwata","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABIUlEQVRIie2QMUvDQBiGv+ODZEnNelnSv3DlBhFKfktCoFOGguBi0YBwLv0B6c/I4nwlkCxBHSsdzNHB1bGDSpNqsGAaV8F7hvfe++CB7w5Ao/mDMKzDb5oZf09J21mPQsGS7Qx/Ub5OCtTvULo4NQeqUsK7shcvj/A684BJe6kWYgz2rYTz6U/l7MbkLBAhpetoSpI8rBXEUSomQEsfeNKxWGYYNLhDCuvIx0EsgT1vDEeJDGAFwK2jyjUdPpU+vjeKxE9l2K9klK1MiaRV0lphxxVkwUfhpGUEy3keWo5EPkruJ9aoDOLOtzzkRG3LS9stClVtZ557IolS84ux6xZZzjt+7ACLySb3nRhNIYL3GmBWB5e3feKmX9FoNJr/wQ6IbGKVDsSrzQAAAABJRU5ErkJggg==","orcid":"","institution":"The University of Tokyo","correspondingAuthor":true,"prefix":"","firstName":"Hiroyoshi","middleName":"","lastName":"Iwata","suffix":""}],"badges":[],"createdAt":"2026-03-24 23:38:13","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-9216494/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-9216494/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":109454646,"identity":"dd3961f7-2fb3-4737-b58d-b647785ff2ff","added_by":"auto","created_at":"2026-05-18 09:42:07","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1058046,"visible":true,"origin":"","legend":"","description":"","filename":"RPGSmanuscriptver5.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9216494/v1_covered_1c204814-d152-4406-964c-ff6cd005ad43.pdf"},{"id":106231585,"identity":"e5db0af0-7a37-44e8-bd55-339f5516780d","added_by":"auto","created_at":"2026-04-06 12:43:44","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":984478,"visible":true,"origin":"","legend":"","description":"","filename":"RPGSsupplement.docx","url":"https://assets-eu.researchsquare.com/files/rs-9216494/v1/7093473c6b1768b5d88f0c3b.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Progeny-based genomic selection reveals untapped genetic potential in an underutilized medicinal plant, Perilla frutescens","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Crossing experiment, genome-assisted breeding, genomic selection, medicinal plants, Perilla frutescens","lastPublishedDoi":"10.21203/rs.3.rs-9216494/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-9216494/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eDespite their substantial therapeutic value, medicinal plants have undergone limited genetic improvement through breeding because of the scarcity of expert breeders. Moreover, quantifying bioactive compounds is expensive. Genomic selection, which leverages genome-wide markers to predict breeding values and assemble favorable alleles, offers a practical way to unlock latent genetic potential. As a model case, we evaluated genomic selection in red perilla (\u003cem\u003ePerilla frutescens\u003c/em\u003e). Building on previous work, we implemented a cross-selection strategy that prioritized segregation variance by selecting crosses based on predicted additive genotypic values of the progeny, and evaluated its effectiveness through actual crossing experiments targeting three key medicinal compounds. Progeny from genomic selection-based crosses (Crs1\u0026ndash;Crs7) outperformed those from phenotypic selection (Crs8) in the G\u003csub\u003e2\u003c/sub\u003e generation, demonstrating a higher mean, greater variance, and superior top individuals. The best G\u003csub\u003e2\u003c/sub\u003e individual exhibited nearly twofold higher levels of two target compounds relative to the existing cultivar \u0026lsquo;Sekiho\u0026rsquo;. This study provides the first empirical demonstration that genomic selection can improve multiple medicinal compounds in red perilla and highlights the effectiveness of cross-selection based on predicted progeny performance. In addition, the evidence presented here supports the broader application of genomic selection in underutilized medicinal plants.\u003c/p\u003e","manuscriptTitle":"Progeny-based genomic selection reveals untapped genetic potential in an underutilized medicinal plant, Perilla frutescens","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-04-06 12:43:39","doi":"10.21203/rs.3.rs-9216494/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"c712bd03-b027-4d58-8207-ccfd9588424f","owner":[],"postedDate":"April 6th, 2026","published":true,"recentEditorialEvents":[{"type":"decision","content":"Rejected","date":"2026-05-18T09:35:50+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-04-30T03:00:44+00:00","index":13,"fulltext":""}],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2026-05-18T09:40:39+00:00","versionOfRecord":[],"versionCreatedAt":"2026-04-06 12:43:39","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-9216494","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-9216494","identity":"rs-9216494","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00